Trading Signals: ANPC Stock Price Prediction and Forecast (Thu. Jan. 30, 2020 - Fri. May. 13, 2022)(AnPac Bio-Medical Science Co Ltd - ADR)
| ANPC latest price $1.6700 (0.6%) ($1.6700 - $1.6700) on Fri. Nov. 12, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 6.46% (three month average) | RSI | 10 | Latest Price | $1.6700(0.6%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ANPC declines -8.3% a day on average for past five trading days. | Weekly Trend | ANPC declines -15.1% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support ANPC advance at 0% a week (0% probability) EMHY(21%) JNK(20%) EWG(19%) IDRV(18%) LIT(18%) | Factors Impacting ANPC price | ANPC will decline at least -3.23% in a week (0% probabilities). SIL(-24%) SLV(-23%) UUP(-18%) GDX(-18%) GDXJ(-17%) | | | | | Relative Volatility | | | | Market Trend Strength | -3.23% (StdDev 6.46%) | Hourly BBV | 0 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-24.95(-1594.01%) | Resistance Level | $2.52 | 5 Day Moving Average | $1.98(-15.66%) | 10 Day Moving Average | $2.27(-26.43%) | 20 Day Moving Average | $2.52(-33.73%) | To recent high | -52% | To recent low | 1.8% | Market Cap | $14m | | | | Anpac Bio-Medical Science Co. Ltd., is a biotechnology company. It engages in marketing and selling multi-cancer screening and detection test that uses patented cancer differentiation analysis, or CDA, technology and proprietary cancer-detection device or CDA device. The company was founded by Chris Chang Yu and He Yu in 2010 and is headquartered in Lishui, China. |